New Glycyrrhetinic Acid Derivative Shows Anti-Cancer Activity
Author Information
Author(s): Logashenko Evgeniya B, Salomatina Oksana V, Markov A V, Korchagina Dina V, Salakhutdinov Nariman F, Tolstikov Genrikh A, Vlassov Valentin V, Zenkova Marina A
Primary Institution: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences
Hypothesis
Can modifications to glycyrrhetinic acid enhance its anti-cancer properties?
Conclusion
The novel derivative methyl 2-cyano-3,12-dioxo-18βH-olean-9(11),1(2)-dien-30-oate exhibits significant anti-cancer activity, inducing apoptosis in cancer cells.
Supporting Evidence
- The new derivative showed lower IC50 values compared to existing compounds.
- Compound 12 induced significant cell death in multiple cancer cell lines.
- Apoptosis was confirmed through various assays including annexin V binding and mitochondrial potential analysis.
Takeaway
Scientists created a new version of a natural compound that helps fight cancer, and it works better than the original.
Methodology
The study involved synthesizing a new derivative of glycyrrhetinic acid and testing its effects on various cancer cell lines using the MTT assay.
Limitations
The study primarily focused on in vitro results, which may not fully represent in vivo efficacy.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website